Your browser doesn't support javascript.
loading
[Criteria for the optimal use of interleukin-6 receptor blockers in patients with COVID-19].
Kruglova, T S; Fomina, D S; Poteshkina, N G; Frolova, N F; Beloglazova, I P; Mutovina, Z Y; Samsonova, I V; Kovalevskaja, E A; Zagrebneva, A I; Serdotetckova, S A; Chernov, A A; Lysenko, M A.
Afiliação
  • Kruglova TS; City Clinical Hospital №52.
  • Fomina DS; City Clinical Hospital №52.
  • Poteshkina NG; Sechenov First Moscow State Medical University (Sechenov University).
  • Frolova NF; City Clinical Hospital №52.
  • Beloglazova IP; Pirogov Russian National Research Medical University.
  • Mutovina ZY; City Clinical Hospital №52.
  • Samsonova IV; City Clinical Hospital №52.
  • Kovalevskaja EA; Pirogov Russian National Research Medical University.
  • Zagrebneva AI; City Clinical Hospital №52.
  • Serdotetckova SA; Central State Medical Academy of the President of the Russian Federation.
  • Chernov AA; City Clinical Hospital №52.
  • Lysenko MA; City Clinical Hospital №52.
Ter Arkh ; 93(11): 1316-1324, 2021 Nov 15.
Article em Ru | MEDLINE | ID: mdl-36286654
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: Ru Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: Ru Ano de publicação: 2021 Tipo de documento: Article